PIQLF (Proteomics International Laboratories) Net Income (Continuing Operations): $-6.41 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PIQLF Proteomics International Laboratories Ltd PIQLF
31 GF Score
Price $0.26
GF Value $0.64
! 3 Warning Signs
View Full Analysis

What is Proteomics International Laboratories Net Income (Continuing Operations)?

Proteomics International Laboratories PIQLF -16.13% 31 Net Income (Continuing Operations) is $-6.41 Mil as of Dec. 2025. GuruFocus rates PIQLF with a GF Score™ of 31/100 and a GF Value™ of $0.64. The stock has 3 warning signs investors should review.

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Proteomics International Laboratories's Net Income (Continuing Operations) for the six months ended in Dec. 2025 was $-4.03 Mil. Its Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 was $-6.41 Mil.

Proteomics International Laboratories  (OTCPK:PIQLF) Net Income (Continuing Operations) Explanation

Net Income (Continuing Operations) excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Proteomics International Laboratories Net Income (Continuing Operations) Related Terms

Proteomics International Laboratories Net Income (Continuing Operations) Historical Data

* Premium members only.

The historical data trend for Proteomics International Laboratories's Net Income (Continuing Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteomics International Laboratories Net Income (Continuing Operations) Chart

Proteomics International Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Net Income (Continuing Operations)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.19 -3.50 -4.18 -4.30 -5.31

Proteomics International Laboratories Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Net Income (Continuing Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.56 -1.77 -2.85 -2.38 -4.03
PIQLF
31GF Score
Proteomics International Laboratories Ltd PIQLF
Net Income (Continuing Operations) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proteomics International Laboratories Net Income (Continuing Operations) Calculation

Net Income (Continuing Operations) indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period.

Net Income (Continuing Operations) for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-6.41 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Income (Continuing Operations) of $-6.41 Mil mean?
Proteomics International Laboratories (PIQLF) has a Net Income (Continuing Operations) of $-6.41 Mil as of Dec. 2025. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Proteomics International Laboratories and its competitors.
Is Proteomics International Laboratories' Net Income (Continuing Operations) too high?
Proteomics International Laboratories' current Net Income (Continuing Operations) is $-6.41 Mil. Overall, Proteomics International Laboratories has a GF Score™ of 31/100, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' Net Income (Continuing Operations) compare to VRTX and REGN?
Proteomics International Laboratories' Net Income (Continuing Operations) of $-6.41 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Income (Continuing Operations) for a Biotechnology company?
A good Net Income (Continuing Operations) depends on the Biotechnology industry context. However, Net Income (Continuing Operations) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Income (Continuing Operations) mean?
A high Net Income (Continuing Operations) can signal that a stock is expensive relative to its fundamentals. Net Income (Continuing operations) is the total net earnings from a company's continuing operations. View historical data on Proteomics International Laboratories and its competitors. Proteomics International Laboratories's current Net Income (Continuing Operations) is $-6.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Proteomics International Laboratories (PIQLF) has a current Net Income (Continuing Operations) of $-6.41 Mil. The stock's GF Value™ is $0.64, compared to a current price of $0.26 — trading 59.4% below its estimated fair value. The current Net Income (Continuing Operations) is $-6.41 Mil. Proteomics International Laboratories' overall GF Score™ is 31/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Income (Continuing Operations) calculated?
Net Income (Continuing Operations) is calculated from a company's financial statements. For Proteomics International Laboratories (PIQLF), the current Net Income (Continuing Operations) is $-6.41 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Proteomics International Laboratories (PIQLF) Overvalued in 2026?

Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued. The current stock price of $0.26 is trading 59.4% below its estimated GF Value™ of $0.64.

Key valuation signals for PIQLF:

  • Net Income (Continuing Operations): $-6.41 Mil
  • GF Value™: $0.64 vs. price of $0.26 (59.4% below fair value)
  • GF Score™: 31/100 with 3 warning signs

No single metric tells the full story. See the PIQLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proteomics International Laboratories Business Description

Other Exchanges PIQ:Australia
Address 6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
31GF Score

Get the complete analysis for PIQLF

Net Income (Continuing Operations) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.64
GF Value